MedPath

Effect of Intraperitoneal Nebulisation of Magnesium Sulphate for Analgesia Following Laparoscopic Cholecystectomy

Phase 4
Conditions
Postoperative Pain
Interventions
Registration Number
NCT01542697
Lead Sponsor
B.P. Koirala Institute of Health Sciences
Brief Summary

intraperitoneal nebulisation with magnesuim sulphate will reduce post operative pain and analgesic consumption in postoperative period following laparoscopic cholecystectomy.

Detailed Description

Sixty patients undergoing laparoscopic cholecystectomy belonging to American Society of Anaesthesiologist (I-II) of age 18-65 yrs will be enrolled.Group one (n=30) will receive 1.5 gm magnesium sulphate diluted in 3ml of normal saline and group 2 (n=30) will receive 5 ml of NS.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

ASA I-II

Exclusion Criteria

history of

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Magnesium sulphateintraperitoneal nebulisation of magnesium sulphateintraperitoneal nebulisation of 1.5 gm of magnesium sulphate with 2 ml of normal saline at the end of surgery before closure
normal salineintraperitoneal nebulisation of magnesium sulphateintraperitoneal nebulisation of 5 ml of normal saline after end of surgery before closure
Primary Outcome Measures
NameTimeMethod
number of analgesic request24 hour

time to first analgesic request is taken as duration of effective analgesia

number of analgesic request in first 24 hours were also counted

Secondary Outcome Measures
NameTimeMethod
VAS scorefirst complaint of pain, 6 hrs, 12 hrs, 24 hrs

Visual analogue scale is a linear 10cm scale with 0 corresponding to no pain and 10 to worst pain ever

nausea and vomiting24 hrs
respiratory rate24 hrs
sedation24hrs

Trial Locations

Locations (1)

routine operation theatre of BPKoirala

🇳🇵

Dharan, Nepal

© Copyright 2025. All Rights Reserved by MedPath